[Press Release]: PPCE Expands Partnership with Medidata

gwenda Uncategorised Leave a Comment

PPCE Expands Partnership with Medidata Jan 8, 2018 – Phoenix Progressive Certifications Enterprise Pvt. Ltd. (PPCE), a provider of Clinical Data Management, Biostatistics and Medical Writing services for global pharmaceutical and medical device companies, announced today that it has furthered its partnership with  Medidata (NASDAQ: MDSO), the leading global provider of cloud-based technology and data analytics for clinical research. The …

[FREE DOWNLOAD]: ChemAxon Brochure

gwenda Uncategorised Leave a Comment

CHEMAXON, THE INTEGRATED SCIENTIFIC SOFTWARE PROVIDER of solutions, platforms, applications and consultancy services to handle chemical and biological entities in life sciences, biotechnology, new materials, fine-, petro- and agrochemical, food, flavors and fragrances industries. Our applications and services help optimize the value of information in life sciences and other R&D environments. Our mission is to inspire scientists to manage their …

Did You Know? The Straight Facts about the Metabolic Disease Epidemic in Asia

mildred Uncategorised Leave a Comment

Metabolic diseases are one of many healthcare threats faced by the region, and Johnson & Johnson Innovation is committed to working with local governments, industry experts and innovators to develop solutions for patients across the region. Singapore is one of the major innovation hotspots where Johnson & Johnson Innovation is heavily investing efforts to strengthen its entrepreneurial ecosystem, beginning with …

Johnson & Johnson Innovation Strengthens Innovation Hubs in Asia Pacific through Singapore QuickFire Challenge – Metabolic Disease Innovation

mildred Uncategorised Leave a Comment

Asia Pacific is a region changing at a sometimes dizzying pace. Already comprising 60% of the world’s population, it is growing by some 14 million people per year.  Urbanisation is happening at a pace the world has never seen before,  allowing the equally unprecedented growth of the middle class.  Add to the mix some of the world’s most aging populations, …

Download inVentiv Health’s whitepaper on Understanding the Continuum of Clinical Collaboration: Maximizing Partner Relationships and Unlocking Greater Value

mildred Uncategorised Leave a Comment

As biopharma companies evaluate strategies to advance their products to market, they are increasingly doing so with new options on partnership.  CRO or Vendor partners are invited to solve challenges of capacity, quality, expertise, and infrastructure – but not necessarily all at the same time.  Effective solutions are therefore about taking the BEST approach (Blended Efficient Sustainable Team) that may …

Sponsored Blogpost

mildred Uncategorised Leave a Comment

COMPANY INTRODUCTION Lumosa Therapeutics is dedicated to the development of innovative new drugs for the treatment of neurological and inflammatory diseases with unmet medical needs. The company is actively engaged in scientific licensing and new drug development under the “RESEARCH and DEVELOPMENT” model. This model is executed by a highly capable and experienced multi-functional team of translational research, CMC, preclinical, …

Biopolis – Asia’s Premier Biomedical Hub

mildred Uncategorised Leave a Comment

  As the lead government agency responsible for the development of industrial infrastructure to support and catalyse the growth of industries and enterprises in Singapore, JTC has pioneered and developed innovative infrastructure solutions to meet the unique needs of the biomedical industry. One of these is Biopolis @ one-north, a world-class, purpose-built biomedical research and development hub. With 13 buildings …

Rare Disease Day – The Fight Against Rare Diseases

mildred Uncategorised Leave a Comment

First launched by EURORDIS and its Council of National Alliances in 2008, Rare Disease Day is now in its 9th year and is recognized in over 80 countries on the last day of February each year. The main objective of Rare Disease Day is to raise awareness amongst the general public and decision-makers about rare diseases and their impact on …